{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:07:09Z","timestamp":1782868029517,"version":"3.54.5"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background: Several pharmacological therapeutic approaches have been proposed to manage osteoarthritis (OA), including intra-articular (IA) injections. Although the discovery of clodronate, a bisphosphonate, dates back to the 1960s and the effects of its IA administration have been investigated for decades in animal models, mechanisms of action of this drug are not quite clear, particularly in OA. This scoping review is an overview of the biological as well as the clinical role of clodronic acid in OA. Method: A scoping review based on the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) model was performed to characterize the mechanisms of action of IA clodronate in OA and to evaluate its efficacy from a clinical point of view. Results: Several effects of clodronate have been observed in animal models of OA, including depletion of synovial lining cells that results in reduced production of chemokines (IL-1, TNF- \u03b1), growth factors (TGF-\u03b2, BMP 2\/4), and metalloproteases (MMP 2\/3\/9); prevention of cartilage damage, synovial hyperplasia, and proteoglycans loss; reduction in joint inflammation, joint swelling, and osteophyte formation. From a clinical perspective, patients with knee OA treated with IA clodronate experienced improvements in pain and joint mobility. Conclusion: Clodronate appears to have different mechanisms of action interfering with the pathogenic processes contributing to OA development and progression. This intervention demonstrated positive effects for patients affected by knee OA.<\/jats:p>","DOI":"10.3390\/ijms22052693","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T20:20:43Z","timestamp":1615148443000},"page":"2693","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-2891","authenticated-orcid":false,"given":"Antimo","family":"Moretti","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paoletta","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Liguori","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ilardi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Snichelotto","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Toro","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gimigliano","sequence":"additional","affiliation":[{"name":"Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Iolascon","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties and Dentistry, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"ref_1","unstructured":"March, L., Cross, M., and Lo, C. (2021, January 02). Osteoarthritis: A Serious Disease: Submitted to the U.S. Food and Drug Administration. Available online: https:\/\/www.oarsi.org\/sites\/default\/files\/docs\/2016\/oarsi_white_paper_oa_serious_disease_121416_1.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.eurger.2017.07.008","article-title":"Early osteoarthritis: How to define, diagnose, and manage. A systematic review","volume":"8","author":"Iolascon","year":"2017","journal-title":"Eur. Geriatr. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cpha.2020.08.003","article-title":"Osteoarthritis and Its Management: What the Physician Assistant Needs to Know","volume":"6","author":"Huffman","year":"2021","journal-title":"Physician Assist. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological Assessment of Osteo-Arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1148\/radiol.2019190341","article-title":"Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought?","volume":"293","author":"Kompel","year":"2019","journal-title":"Radiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17425247.2020.1783234","article-title":"The perspectives of intra-articular therapy in the management of osteoarthritis","volume":"17","author":"Migliore","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_9","first-page":"1315","article-title":"Use of clodronate in the management of osteoarthritis: An update","volume":"33","author":"Saviola","year":"2019","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00296-014-3100-5","article-title":"Effects of intra-articular clodronate in the treatment of knee osteoarthritis: Results of a double-blind, randomized placebo-controlled trial","volume":"35","author":"Rossini","year":"2015","journal-title":"Rheumatol. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0168-3659(95)00031-3","article-title":"Studies on liposome formulations for intra-articular delivery of clodronate","volume":"35","author":"Liukkonen","year":"1995","journal-title":"J. Control. Release"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00290330","article-title":"Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate","volume":"13","author":"Bersselaar","year":"1993","journal-title":"Rheumatol. Int."},{"key":"ref_14","first-page":"1226","article-title":"In vivo role of phagocytic synovial lining cells in onset of experimental arthritis","volume":"143","author":"Hoek","year":"1993","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/ard.57.7.408","article-title":"Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis","volume":"57","author":"Lent","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","first-page":"43","article-title":"A trial of clodronate-liposomes as anti-macrophage treatment in a sheep model of arthritis","volume":"17","author":"Highton","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/1529-0131(200108)44:8<1908::AID-ART329>3.0.CO;2-4","article-title":"Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits","volume":"44","author":"Ceponis","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/joca.2000.0368","article-title":"Overexpression of active TGF-beta-1 in the murine knee joint: Evidence for synovial-layer-dependent chondro-osteophyte formation","volume":"9","author":"Bakker","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.joca.2004.03.003","article-title":"Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis","volume":"12","author":"Blom","year":"2004","journal-title":"Osteoarthr. Cartil."},{"key":"ref_20","first-page":"622","article-title":"Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis","volume":"24","author":"Lindroos","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.22337","article-title":"Crucial role of macrophages in matrix metalloproteinase\u2013mediated cartilage destruction during experimental osteoarthritis: Involvement of matrix metalloproteinase 3","volume":"56","author":"Blom","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_22","first-page":"1","article-title":"Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation","volume":"9","author":"Sun","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/rheumatology\/kep084","article-title":"Intra-articular clodronate for the treatment of knee osteoarthritis: Dose ranging study vs hyaluronic acid","volume":"48","author":"Rossini","year":"2009","journal-title":"Rheumatology"},{"key":"ref_24","first-page":"7","article-title":"Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain","volume":"7","author":"Palmieri","year":"2013","journal-title":"Drug Des. Develop. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: Evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.23736\/S0026-4806.18.05688-4","article-title":"Clodronate in the management of different musculoskeletal conditions","volume":"109","author":"Frediani","year":"2018","journal-title":"Minerva Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(85)90007-1","article-title":"The synovial lining cell: Biology and pathobiology","volume":"15","author":"Henderson","year":"1985","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0928-0987(98)00065-7","article-title":"Contrasting effects of alendronate and clodronate on RAW 264 macrophages: The role of a bisphosphonate metabolite","volume":"8","author":"Makkonen","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1063-4584(03)00004-9","article-title":"Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte","volume":"11","author":"Nakase","year":"2003","journal-title":"Osteoarthr. Cartil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1469-7580.2003.00158.x","article-title":"Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans","volume":"202","author":"Zoricic","year":"2003","journal-title":"J. Anat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/joca.1998.0122","article-title":"Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis","volume":"6","author":"Mehraban","year":"1998","journal-title":"Osteoarthr. Cartil."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tzschentke, T.M. (2019). Pharmacology of bisphosphonates in pain. Br. J. Pharmacol.","DOI":"10.1111\/bph.14799"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E6297","DOI":"10.1073\/pnas.1704847114","article-title":"Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain","volume":"114","author":"Kato","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tips.2017.10.007","article-title":"Clodronate: A Vesicular ATP Release Blocker","volume":"39","author":"Moriyama","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid","volume":"302","author":"Wood","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/keq188","article-title":"Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis","volume":"49","author":"Walsh","year":"2010","journal-title":"Rheumatology"},{"key":"ref_37","first-page":"2187","article-title":"Periarticular osteoporosis in osteoarthritis of the knee","volume":"25","author":"Karvonen","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_38","first-page":"445","article-title":"Osteoarthritis of the knee: Correlation of subchondral MR signal abnormalities with histopathologic and radiographic features","volume":"23","author":"Bergman","year":"1994","journal-title":"Skelet. Radiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2006.04.033","article-title":"Osteoclasts play a part in pain due to the inflammation adjacent to bone","volume":"39","author":"Nagae","year":"2006","journal-title":"Bone"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bonekey.2015.58","article-title":"Acidic microenvironment and bone pain in cancer-colonized bone","volume":"4","author":"Yoneda","year":"2015","journal-title":"BoneKEy Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.joca.2016.05.009","article-title":"Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesis","volume":"24","author":"Shabestari","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-020-03574-x","article-title":"Transient osteoporosis of the hip and subclinical hypothyroidism: An unusual dangerous duet? Case report and pathogenetic hypothesis","volume":"21","author":"Paoletta","year":"2020","journal-title":"BMC Musculoskelet. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ard.2010.131904","article-title":"Do knee abnormalities visualised on RI explain knee pain in knee osteoarthritis? A systematic review","volume":"70","author":"Yusuf","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00167-016-4113-2","article-title":"Bone marrow lesions and subchondral bone pathology of the knee","volume":"24","author":"Kon","year":"2016","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomised controlled trial","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/rheumatology\/kev123","article-title":"Intravenous neridronate in the treatment of acute painful knee osteoarthritis: A randomized controlled study","volume":"54","author":"Varenna","year":"2015","journal-title":"Rheumatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2693\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:34:25Z","timestamp":1760160865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijms22052693"],"URL":"https:\/\/doi.org\/10.3390\/ijms22052693","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,7]]}}}